Vitiligo Clinical Trial
Center for Dermatology Clinical Research in Fremont, CA is conducting a new clinical study evaluating a new investigational treatment option for vitiligo. There is no placebo. This is a paid clinical research opportunity sponsored by Teva Pharmaceuticals.
Study Overview
Who Qualifies? Male or female patients ages 18-75 with vitiligo
Study Duration: 24 weeks + 1 year followup
Protocol: TV53408-IMM-10209